Precipio Inc (PRPO)
NASDAQ:PRPO
Want to see PRPO full AI Analyst Report?
Earnings Data
Report Date
Aug 04, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
―Last Year’s EPS
0.05Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a mix of strong underlying trends and short-term headwinds. Positives include >30% YoY revenue growth, a growing pathology business, a $10M annualized commercial pipeline and positive operating cash flow. Near-term negatives included an 8% CMS reimbursement cut causing a ~$0.5M write-down, a QoQ gross margin decline (47% to 40%), and an adjusted EBITDA decline to -$200k driven by timing and investment-related factors. Management framed most negatives as one-time or investment-driven and emphasized scalability, available lab capacity, and commercial momentum, with expectations for margin recovery as product revenue scales.Company Guidance
Commercial Team and Pipeline Build
New commercial team established relationships with ~20 distributor reps, identified 10 new qualified customer opportunities, added approximately $3 million of annualized revenue potential in Q1; combined pipeline now ~ $10 million of annualized revenue potential.
Positive Operating Cash Flow and Manageable Seasonality
Cash flow from operations remained positive at approximately $60,000 for the quarter despite total cash flow being slightly negative (~$40,000); management described this as seasonality and normal year-start patterns.
Lab Capacity and Scalability
Current pathology services are operating at approximately $24 million on an annualized basis with estimated lab capacity of $45–$50 million before significant CapEx is required, indicating room for organic scaling and potential operational leverage.
Total Revenue Stability and Year-over-Year Growth
Total revenue for Q1 2026 was $6.71 million, flat quarter-over-quarter (0% QoQ) and up over 30% year-over-year.
Pathology Revenue Growth
Pathology revenue was a little over $6.0 million in Q1, up from $5.9 million in Q4 and up 36% versus $4.4 million in Q1 of last year.
Product Business Predictability Once Live
Management reported that product revenues are stable and predictable once a customer is onboarded; Q1 product revenue was $660,000 (down $80,000 from $740,000 in Q4 due to shipment timing).
PRPO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PRPO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2026 | $28.60 | $26.04 | -8.95% |
Apr 06, 2026 | $25.40 | $25.98 | +2.28% |
Nov 14, 2025 | $19.33 | $21.03 | +8.79% |
Aug 13, 2025 | $14.29 | $14.71 | +2.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Precipio Inc (PRPO) report earnings?
Precipio Inc (PRPO) is schdueled to report earning on Aug 04, 2026, TBA (Confirmed).
What is Precipio Inc (PRPO) earnings time?
Precipio Inc (PRPO) earnings time is at Aug 04, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRPO EPS forecast?
Currently, no data Available